Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991;105(4):578-82.
doi: 10.1007/BF02244384.

Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal

Affiliations

Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal

S E File et al. Psychopharmacology (Berl). 1991.

Abstract

After 21 days of treatment with diazepam (2 mg/kg/day IP) rats were tested 24 h after the last injection in the social interaction and elevated plus-maze tests of anxiety. Compared with control-treated rats, they showed significant decreases in social interaction, in the % numbers of entries onto open arms of the plus-maze and in the % of time spent on the open arms, indicating an anxiogenic response on withdrawal from diazepam. Buspirone (200 micrograms/kg SC) significantly increased social interaction in diazepam withdrawn rats and in the plus-maze also this dose significantly reversed the anxiogenic effects of diazepam withdrawal. Buspirone (400 micrograms/kg SC) was without effect in the plus-maze, but buspirone (800 micrograms/kg SC) significantly decreased the % of time spent on open arms in control-treated rats, indicating an anxiogenic effect. In the social interaction test buspirone (800 micrograms/kg SC) was without significant effect. The contrasting effects of the 200 and 800 micrograms/kg doses are discussed in terms of the pre- and post-synaptic actions of buspirone. The findings are consistent with earlier proposals that the increased anxiety during benzodiazepine withdrawal is at least partly caused by an increased release of hippocampal 5-HT.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Psychopharmacology (Berl). 1990;101(4):525-32 - PubMed
    1. Br J Pharmacol. 1987 Jul;91(3):517-22 - PubMed
    1. Eur J Pharmacol. 1989 Oct 4;169(1):1-10 - PubMed
    1. J Pharm Pharmacol. 1987 Nov;39(11):917-28 - PubMed
    1. Eur J Pharmacol. 1986 Sep 23;129(1-2):123-30 - PubMed

Publication types